Rapidly giving intravenous fluid to prevent or treat shock (fluid resuscitation) is one of the commonest treatments given to critically ill patients. Current guidelines recommend crystalloid solutions but it is unknown whether any particular crystalloid is better than others. This trial will determine whether the use of one of two crystalloid fluids, saline or PlasmaLyte, reduces the risk of organ injuries, such as kidney failure, and improves patients chances of surviving critically illness.
Re-EValuating The Inhibition Of Stress Erosions (REVISE): Gastrointestinal Bleeding Prophylaxis In ICU
Funder
National Health and Medical Research Council
Funding Amount
$2,955,164.00
Summary
Around 50,000 patients in Australian Intensive Care Units receive a drug called pantoprazole each year with the aim of preventing bleeding from the gut. Recent research suggests this practice is ineffective and may harm patients by increasing their risk of serious infections. We will perform a definitive study to determine whether the widespread use of pantoprazole is beneficial or harmful.
Improving The Cardiometabolic Health Of People With Psychosis: The Physical Health Nurse Consultant Service
Funder
National Health and Medical Research Council
Funding Amount
$667,021.00
Summary
People with psychosis have high rates of chronic disease that reduces lifespan by 25 years. The health system struggles to provide adequate care. We developed the Physical Health Nurse Consultant service that provides physical health care coordination and will evaluate whether it improves physical health, consumer experience and cost-effectiveness. Outcomes will directly address policy initiatives to improve physical health service delivery in mental health services.